Search
Skip to Search Results- 1Brown, Douglas Wilson
- 1Campbell, Stuart D.
- 1DeSilva, Alan D
- 1Dobberthien, Brennen Jay
- 1Friesen, Douglas E
- 1Jutras, Jean-David
-
Fall 2010
Patients diagnosed with malignant glioma tumours have median survivals of 1.6 yrs and 5 months, respectively, highlighting the deadly nature of this disease. Despite aggressive multimodal treatment, patients with malignant glioma often present with secondary brain tumours at sites distal to the...
-
Spectral Editing for Detection of Oncologically Relevant Metabolites with In-Vivo Magnetic Resonance Spectroscopy at 9.4 T
DownloadFall 2019
Short echo time (TE) magnetic resonance spectroscopy (MRS) techniques with spectral fitting are commonly employed approaches for brain metabolite quantification at 9.4 T. However, there is a significant overlap of peaks in short-TE spectra, even at 9.4 T. To better resolve resonances, spectral...
-
Fall 2014
Chemoresistance is one of the major hurdles to induce a cure in patients with epithelial ovarian cancer (EOC). RUNX3, belonging to the family of RUNX transcription factors, has been shown to act in an oncogenic manner by promoting proliferation and colony formation when overexpressed, in EOC....
-
Spring 2017
Quantitative Magnetic Resonance Imaging (qMRI) is occupying an increasingly prominent role in the study of the brain, by virtue of its sensitivity to physiological and anatomical changes. However, because qMRI techniques tend to suffer from long scan durations and/or post-processing times, as...